Please join us in welcoming Willard Den Houter, MD, to IHA Internal Medicine & Pediatrics – Plymouth. He has clinical interests in risk factor modification and preventive medicine. To learn more about Dr. Den Houter, please click here.
IHA is pleased to accept most major insurances, including U-M Premier Care as a tier 1 provider. This means you can see IHA primary care providers without the need of a referral, and with no additional out-of-network costs. We have physicians at all of our locations who are accepting new patients. We also offer the opportunity to schedule appointments online, in addition to calling the office.
June 28, 2017
For Immediate Release
For more information, contact:
IHA Welcomes New Chief Executive Officer
Mark A. LePage, MD, MBA, to join one of Michigan’s largest multi-specialty medical groups
ANN ARBOR, MI – (June 28, 2017) – With the extensive recruitment process completed, IHA’s Governing Board is pleased to announce that Mark A. LePage, MD, MBA, will succeed the late Bill Fileti, to serve as the organization’s next CEO and the first physician CEO in the medical group’s 23-year history.
CEO Search Committee Chair and IHA OB/GYN, Wesley Beemer, MD, said, “We were delighted by the interest in our position from physician candidates across the country. All of the candidates were physician executives with extensive experience with large multi-specialty group practices, hospital systems and a couple with health plan experience as well.”
Dr. LePage is a physician executive with a wide-array of experience in both provider and payer matters and a unique skill set encompassing clinical experience, financial acumen and strategic mindset with a passion for driving change toward a sustaining health care system that delivers affordable care, delights patients, engages physicians and other clinical professionals, and improves overall community health. After serving in the United States Air Force as a Staff Interventional Radiologist, Dr. LePage joined Marshfield Clinic in Wisconsin.
Early in his tenure at Marshfield, he served as Medical Director of Marshfield Clinic Vascular Center and has continued to serve on the Marshfield Board or other leadership roles since 2010. In January 2013, Mark accepted the Chief Medical Officer position at Security Health Plan. SHP is a subsidiary of Marshfield Clinic Health System. In January 2016, Mark was selected for the role of Chief Medical Officer at Marshfield Clinic.
IHA’s incoming CEO grew up in Marquette, Michigan. He went to the University of Michigan for his undergraduate degree, and then attended the University of Michigan Medical School for his medical degree. Dr. LePage completed his residency in Diagnostic Radiology and Fellowship in Vascular and Interventional Radiology at University of Michigan Health System. Dr. LePage obtained his MBA and his MS in Finance from the Kelley School of Business at Indiana University.
“Mark brings great interpersonal relationship skills and a successful track record managing complex organizational initiatives to his new position with IHA,” said Rob Casalou, Regional President and CEO for Saint Joseph Mercy Health System and IHA Board member. “His collaborative approach, high integrity and extensive knowledge of health care operations will be a tremendous asset as IHA continues to grow and provide care across multiple specialties.”
Mark and his wife Heather, who is a CPA by training and a University of Michigan graduate, have three children ages 18, 16 and 14. They view IHA’s CEO position as “an opportunity of a lifetime” and are looking forward to returning “home” to Michigan in early fall.
IHA is one of the best and largest multi-specialty groups in Michigan. IHA employs nearly 2,200 staff, which includes more than 650 providers consisting of: physicians, nurse practitioners, physician assistants and midwives in approximately 70 practice locations across Southeast Michigan. IHA provides high-quality medical care and excellent service to nearly 470,000 active patients. Recognized as Metro Detroit’s Top Physician Group by Consumer Reports magazine, IHA also ranks in the top quartile for patient satisfaction nationally. Offering extended office hours and urgent care services, along with online patient diagnosis, treatment and appointment access tools. IHA demonstrates that it cares by bringing safe, high quality, comprehensive and affordable care to its patients. For more information about IHA, visit www.ihacares.com.
About Trinity Health
Trinity Health is one of the largest multi-institutional Catholic health care delivery systems in the nation, serving diverse communities that include more than 30 million people across 22 states. Trinity Health includes 93 hospitals, as well as 120 continuing care programs that include PACE, senior living facilities, and home care and hospice services. Its continuing care programs provide nearly 2.5 million visits annually. Based in Livonia, Mich., and with annual operating revenues of $16.3 billion and assets of $23.4 billion, the organization returns almost $1 billion to its communities annually in the form of charity care and other community benefit programs. Trinity Health employs about 131,000 colleagues, including 5,300 employed physicians. For more information about Trinity Health, visit www.trinity-health.org.
April 5, 2017
For Immediate Release
For more information, contact:
IHA Recognized by DecisionWise as 2017 Employee Engagement Best Practice Award Winner
ANN ARBOR, MI – (April 5, 2017) – IHA is pleased to announce that DecisionWise, a US-based employee engagement consulting firm, recognizes IHA as a top performing organization with the 2017 Employee Engagement Best Practice Award. IHA is one of 115 companies who participated in the DecisionWise international employee survey.
Over seven million survey responses were cast for the 35 companies with more than 1,000 employees, including IHA. Surveys results were analyzed to measure the level of engagement within each organization. Final winners were confirmed by evaluating the overall culture of the organization as well as best practices and company initiatives that contribute to the scores.
“We’re proud and honored by this recognition from DecisionWise,” notes Linda MacEllven, Vice President of Human Resources & Customer Service for IHA. “At IHA we value employee feedback and strive to promote a culture where employees take personal satisfaction in the quality of their work and the difference they can make in every customer experience, whether external or internal.”
“We’re privileged that IHA has made DecisionWise a strategic partner for employee engagement surveys, and we’re proud that they have taken clear, measurable actions to leverage employee feedback and create a positive, engaging and energizing workplace for their employees,” said DecisionWise Chief Executive Office Dr. Tracy Maylett.
DecisionWise, Inc. is a management consulting firm specializing in leadership and organization development using assessments, feedback, coaching, and training. DecisionWise services include employee engagement surveys, 360-degree feedback, leadership coaching and organization development. DecisionWise was founded in 1996 and is privately held. With offices in the United States and affiliate offices throughout the world, DecisionWise operates in over 70 countries and conducts surveys in over 30 languages.
IHA is one of the best and largest multi-specialty groups in Michigan. IHA employs more than 2,200 staff, which includes nearly 600 providers consisting of: physicians, nurse practitioners, physician assistants and midwives in approximately 60 practice locations across Southeast Michigan. IHA provides high-quality medical care and excellent service to nearly 410,000 active patients. Recognized as Metro Detroit’s Top Physician Group by Consumer Reports magazine, IHA also ranks in the top quartile for patient satisfaction nationally. Offering extended office hours and urgent care services, along with online patient diagnosis, treatment, and appointment access tools. IHA demonstrates that it cares by bringing safe, high-quality, comprehensive and affordable care to its patients. For more information about IHA, visit www.ihacares.com.
If you think you may be impacted by this recall, please follow these steps:
STEP 1: Check the lot number on your carton or device to see if your EpiPen® Auto-Injector is affected by the recall.
STEP 2: If your EpiPen® Auto-Injector has been recalled, contact Stericycle at 877-650-3494 to obtain a voucher code for your free replacement product. Stericycle also will provide you with a pre-paid return package to ship the product back to Stericycle.
STEP 3: Visit your pharmacy with your voucher information to redeem your free replacement.
STEP 4: Send your recalled product to Stericycle. Do not return any devices affected by the recall until you have your replacement in hand.
Stericycle’s hours of operation are Monday-Friday 8:00 am – 10:00 pm, and Saturday and Sunday 8:00 am – 5:00 pm.
Recalled Lots in U.S.
IMPORTANT NOTE: The NDC on the box ends with “2” because it contains two EpiPen Auto-injectors. The NDC on the individual EpiPen within the box has an NDC ending in “1.”
You can confirm if you are in possession of a recalled EpiPen product by checking if the lot number matches any of the lot numbers listed in the above table.
On the auto-injector, the lot number is located at the top of the label in black and preceded by the word ‘LOT.’
On the carton, the lot number is located on the left flap, which is black in color. You will find the lot number written in white and preceded by the word ‘LOT.’If your EpiPen® Auto-Injector has been recalled, contact Stericycle at 877-650-3494 to obtain a voucher code for your free replacement product. If not, there is no further action necessary.
Stericycle will provide you with a voucher code to redeem a free replacement product. If you called before Monday, April 3, Stericycle will follow-up with your voucher code via phone or email beginning Tuesday, April 4.
Each voucher is valid for one EpiPen 2-Pak or EpiPen Jr 2-Pak, or one of Mylan’s authorized generic for EpiPen 2-Pak or EpiPen Jr 2-Pak. Stericycle will issue one voucher for every two-pack that needs to be replaced. Each two-pack carton contains two auto-injectors.
After you have received your voucher, follow these steps:
STEP 1: Call your pharmacy to inform them that you have a voucher for your free replacement of the product.
STEP 2: Confirm with your pharmacy that you have a fillable prescription for EpiPen or Mylan’s authorized generic for EpiPen on file.
STEP 3: Confirm that the pharmacy has the medication in stock.
Patients may receive either EpiPen Auto-Injector or Mylan’s authorized generic for EpiPen Auto-Injector at the pharmacy as a replacement based on availability. The authorized generic has the exact same drug formulation, has the exact same operating instructions and is therapeutically equivalent to EpiPen Auto-Injector, and may be substituted for EpiPen Auto-Injector.
Mylan is committed to replacing recalled devices at no cost and Mylan would like to reassure patients that there will be no additional replacement-related financial burden to them as a result of this recall.
If you are in possession of a recalled product, call Stericycle at 877-650-3494 to provide you with a pre-paid return package to ship the product back to Stericycle.
IMPORTANT: Do not return any devices affected by the recall until you have redeemed your free replacement from your pharmacy and have your replacement in hand.